Figure S3. Antibody array: representative detection of 96 different mouse cytokines. The profiles of cytokine secretion in the conditioned media of (A) non-treated MSCs and (B) TGFĂ1-treated MSCs after three-week culture. (TIF 96864 kb
Myeloid cell reconstitution in spleen and bone marrow. Percentage of myeloid cells (CD33+) in spleen...
Preconditioning of the mouse immune system by IP injected MSC. Live or dead MSC were injected IP int...
Gating strategies for LSKs. BM cells collected from WT or IL-21R−/− C57BL/6 mice were treated in vit...
Table S2. Antibodies used for immunocytochemistry and immunohistochemistry. (DOCX 32 kb
Figure S2. Prepubertal mouse testis tissue was used as a positive control for (A) UCHL1 and (B) SOX9...
Includes supplementary methods, Figure S1 showing effect of IL-3 on expression of human MSC surface ...
Figure S6. Caspase-3 positive control. Mouse liver tissue stained with Caspase-3 acting as positive ...
Figure S1. Flow cytometric determinations of the expression of surface markers in MΦGM or MΦM. Gray-...
Figure S2. Characterization of mouse primary satellite cells. (A) Undifferentiated SC at 60% conflue...
Cells expanded on P-MSCs gave rise to persistent engraftment in NOD/SCID mice. a Superior multi-line...
Figure S1. MSCs pre- and post transplantation. Figure S1A, B mCherry+MSCs prior to transplantation (...
Clinical incidences, average clinical grades, and inverted screen hang times of MuSK-immunized mice ...
Table S1. Cell components in graft. Figure S1. HLA-DR−/lowCD33+CD16− eMDSCs demonstrated superior im...
Cell surface markers and differentiation capacities of mouse MSCs. (A) Flow cytometry analysis resul...
Figure S3. Limiting dilution transplantation series in C57BL/6 and FVB mice. (A) Numbers of cells en...
Myeloid cell reconstitution in spleen and bone marrow. Percentage of myeloid cells (CD33+) in spleen...
Preconditioning of the mouse immune system by IP injected MSC. Live or dead MSC were injected IP int...
Gating strategies for LSKs. BM cells collected from WT or IL-21R−/− C57BL/6 mice were treated in vit...
Table S2. Antibodies used for immunocytochemistry and immunohistochemistry. (DOCX 32 kb
Figure S2. Prepubertal mouse testis tissue was used as a positive control for (A) UCHL1 and (B) SOX9...
Includes supplementary methods, Figure S1 showing effect of IL-3 on expression of human MSC surface ...
Figure S6. Caspase-3 positive control. Mouse liver tissue stained with Caspase-3 acting as positive ...
Figure S1. Flow cytometric determinations of the expression of surface markers in MΦGM or MΦM. Gray-...
Figure S2. Characterization of mouse primary satellite cells. (A) Undifferentiated SC at 60% conflue...
Cells expanded on P-MSCs gave rise to persistent engraftment in NOD/SCID mice. a Superior multi-line...
Figure S1. MSCs pre- and post transplantation. Figure S1A, B mCherry+MSCs prior to transplantation (...
Clinical incidences, average clinical grades, and inverted screen hang times of MuSK-immunized mice ...
Table S1. Cell components in graft. Figure S1. HLA-DR−/lowCD33+CD16− eMDSCs demonstrated superior im...
Cell surface markers and differentiation capacities of mouse MSCs. (A) Flow cytometry analysis resul...
Figure S3. Limiting dilution transplantation series in C57BL/6 and FVB mice. (A) Numbers of cells en...
Myeloid cell reconstitution in spleen and bone marrow. Percentage of myeloid cells (CD33+) in spleen...
Preconditioning of the mouse immune system by IP injected MSC. Live or dead MSC were injected IP int...
Gating strategies for LSKs. BM cells collected from WT or IL-21R−/− C57BL/6 mice were treated in vit...